Term: CDK inhibitor AT7519M Pronunciation: (... in-HIH-bih-ter ...) May 24, 2024October 15, 2024 Description: A substance being studied in the treatment of some types of cancer. CDK inhibitor AT7519M blocks enzymes needed for cells to divide. It is a type of cyclin-dependent kinase inhibitor. Also called AT7519M. Related Posts:Pacritinib for Myelofibrosis - A New JAK-2 Inhibitor…FDA Approves ALIQOPA®, a PI3K Inhibitor, for…FDA Approves ALIQOPA®, a PI3K Inhibitor, for…FDA Approves First PI3K Inhibitor, PIQRAY®, for…LAG-3 Inhibitor Relatlimab and OPVIDO® in…FDA Approves BCL2 Inhibitor VENCLEXTA® for…